Updated:
RiverGlade Capital
RiverGlade Capital is an SEC-registered investment adviser in Chicago, IL, registered since 2019. The firm manages approximately $847 million in regulatory...
RiverGlade Capital
RiverGlade Capital is an SEC-registered investment adviser in Chicago, IL, registered since 2019. The firm manages approximately $847 million in regulatory assets. It has 12 employees and 12 investment advisers.
General information
Firm type
Private Equity
Year founded
2017
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Chicago
Corporate office
One North Wacker Drive Suite 4000 Chicago, IL 60606
Additional offices
612 Beachland Boulevard Vero Beach, FL 32963
Principals
Garrick Rice
Managing Partner
Danny Rosenberg
Managing Partner
Dan Skowronski
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at RiverGlade Capital?
Managing Partners Garrick Rice and Danny Rosenberg lead the firm. Partner Dan Skowronski, Principal Barrett Lynner, Vice Presidents Rachel Lorenc and Colin McBride, and Associates Devin Deogun and Alex Harris fill out the investing team. The firm does not publicly delineate a separate investment committee structure.
How does RiverGlade Capital source deal flow?
RiverGlade's Executive Healthcare Advisory Council participates in origination — members with tenures at companies such as DaVita and AMN Healthcare leverage industry relationships to surface opportunities. The firm also maintains a business development executive partner, Tim Boes, and a business development analyst dedicated to outreach to founder-owned healthcare companies across North America.
Does RiverGlade Capital invest from a fund or a permanent capital vehicle?
The firm's website does not disclose a fund structure or vehicle-specific detail. Based on its closed-end investment attribute range — targeting $15M to $100M equity checks — RiverGlade operates consistent with a traditional commingled private equity fund model rather than a single-family or permanent capital architecture.
What type of healthcare companies does RiverGlade target?
RiverGlade focuses on founder-owned, lower-mid-market businesses with proven organic growth and multiple value-creation levers. Target enterprise values range from $15 million to $300 million, spanning outsourced services, employer health, franchised care delivery, home-based services, hospital and outpatient, payor services, pharma services, specialty staffing, digital health, governance and compliance, and medical products and distribution.
Does RiverGlade Capital take minority stakes or only control investments?
The firm states it pursues control investments and select minority opportunities. The investment criteria page specifies a platform EBITDA ceiling of $20 million, with no minimum for add-on acquisitions.
What role does the Executive Healthcare Advisory Council play?
The 29-member council provides operational guidance, strategic advice, reimbursement and regulatory expertise, and industry relationships to portfolio companies. Council members also serve on portfolio company boards, originate new investments, develop investment theses, and participate in due diligence. The council includes former leaders from BluePearl Veterinary Partners, UnitedHealth Group, LabCorp, DaVita, and Blue Cross Blue Shield of North Carolina.
Where does RiverGlade Capital invest geographically?
RiverGlade focuses exclusively on North America. The firm operates from Chicago, Illinois, and Vero Beach, Florida, and its investment criteria page confirms a North American market focus without further regional breakdown.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: